Brain metastasis from non-small cell lung cancer: sustained response with erlotinib
- 1 May 2009
- journal article
- Published by Elsevier in Community Oncology
- Vol. 6 (5) , 203-204
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2007
- Frequent EGFR mutations in brain metastases of lung adenocarcinomaInternational Journal of Cancer, 2006
- EGFR mutations in patients with brain metastases from lung cancer: Association with the efficacy of gefitinibNeuro-Oncology, 2006
- Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With ErlotinibJournal of Clinical Oncology, 2005
- Treatment of brain metastases from non-small-cell lung cancer (NSCLC): radiotherapyLung Cancer, 2004
- Gefitinib in patients with brain metastases from non-small-cell lung cancer: a prospective trialAnnals of Oncology, 2004